Concepedia

Publication | Open Access

EGFR ligand switch in late stage prostate cancer contributes to changes in cell signaling and bone remodeling

DOIFull Paper Access

44

Citations

33

References

2009

Year

Alyse M. DeHaan, Natalie M. Wolters, Evan T. Keller, Kathleen M. Woods Ignatoski
The Prostate

Abstract

The switch in EGFR ligand availability as PCa progresses affects cell survival and contributes to bone remodeling.

References

YearCitations

Page 1